Northwestern inks $65M investment partnership to support research

Northwestern University announced an investment partnership with Deerfield Management. (Eugene_Moerman)

Northwestern University announced a deal to create a $65 million venture play with New York City-based Deerfield Management to support drug development at the university.

Lakeside Discovery will target funding and development expertise to advance "novel biomedical discoveries" at the university and strengthen its reputation as an academic medical research center, officials said in a release.

Lakeside will take on projects approved by a joint steering committee comprised of members from Northwestern's and Deerfield's scientific leadership teams which have a complete development plan, including experiments needed to reach investigational new drug status.   

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

“Lakeside will highlight Chicago as a preeminent hub for tomorrow’s cures, with the best medical researchers and clinicians working to improve the lives of patients,” said Alicia Löffler, executive director of Northwestern’s Innovation and New Ventures Office (INVO), in a statement.

RELATED: Health technology startups and innovators: Ignore physicians at your product’s peril

The creation of the fund comes as the university plans to open its new Louis A. Simpson and Kimberly K. Querrey Biomedical Research Center in 2019.

The university also has a number of investment partnerships including Baxter International and AbbVie, but none of this size, the Chicago Tribune reported. Deerfield has a similar arrangement with other universities, including Johns Hopkins University.

RELATED: Johns Hopkins, Northwestern lead $25M initiative to create a health informatics collaborative

Deerfield officials said the group is investing in Northwestern, in part, because of its track record in translational research in drug development. Researchers at Northwestern discovered fibromyalgia drug Lyrica, marketed by Pfizer.

“Additionally, supporting life-science discovery with INVO as a resource can help enhance the ecosystem at large in Chicago,” said James Flynn, Deerfield’s managing partner.

Suggested Articles

Humana filed suit Friday against more than a dozen generic drugmakers alleging the companies engaged in price fixing.

Ochsner Health System is partnering with Color to launch a population health pilot program to integrate genetic information into preventive care.

Medicare Advantage open enrollment kicked off last week, and insurers are taking new approaches to marketing a slate of supplemental benefit options.